HR 5202
115th Congress
House
Crime and Law Enforcement
Congressional oversight
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government studies and investigations
Health personnel
Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
Introduced: March 7, 2018
See on congress.gov
Everywhere this bill has been
8 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 9, 2018
Ordered to be Reported by Voice Vote.
May 9, 2018
Committee Consideration and Mark-up Session Held.
Apr 25, 2018
Forwarded by Subcommittee to Full Committee by Voice Vote .
Apr 25, 2018
Subcommittee Consideration and Mark-up Session Held.
Apr 6, 2018
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Mar 9, 2018
Referred to the Subcommittee on Health.
Mar 7, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 7, 2018
Introduced in House
Plain-English summary
Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump.
The bill directs the Government Accountability Office to report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.
What's happening now
Ordered to be Reported by Voice Vote.
Committees of jurisdiction
4